About This Webinar
More than 70% of American adults are diagnosed as overweight or obese, posing significant risks to the health of individuals and challenges to the healthcare system. While the surge in GLP-1 prescriptions has brought national attention to obesity as a chronic condition, these drugs are not meant to be a stand-alone solution. While the clinical outcomes are promising, the drug paired with lifestyle support is best. And even so, a recent JAMA study showed there is up to 53.6% discontinuation rate of GLP-1s within the first year.
We invite you to join this discussion to learn how a balanced approach can better support members. Whether the approach is lifestyle only, clinical support alongside medication or post medication support, sustained weight loss requires continuous, individualized coaching. Our CVS Weight Management program demonstrated 94% sustained weight loss for members who continued engaging in our program 6 months after drug discontinuation.
Attendees Will Learn About
- CVS Healthspire's high-touch, high-tech approach supports members in a 1:1 setting with registered dietitians and medical nutrition therapy paired with digital coaching and tools
- How CVS Healthspire helps clients manage clinical appropriateness of pharmacotherapeutics agents for obesity while providing price transparency
- The latest GLP-1 clinical developments and how they might influence your management strategies
